Tobi Langenhan "I studied medicine at the University of Würzburg, where I obtained my license to practice Shortly after was recruited to the Medical Faculty of Leipzig University, where I now head the Department

Bedside Vision Ben’s work seeks to merge in vitro mechanistic data with in vivo efficacy , guiding medicinal chemists toward creating druggable PAMs .

Any scientist working with GPCRs — pharmacologists, medicinal chemists, cell biologists, translational

antibody molecules blocking and activating the Wnt pathway for the treatment of cancers and regenerative medicine

their defects are signaling pathway-specific opening new perspectives for T2D treatment and precision medicine

Katarina Nemec " I am a pharmacist with an interest in systems pharmacology and precision medicine.

Stephen Ferguson is a Professor in the Department of Cellular and Molecular Medicine at the University

Stephen Ferguson is a Professor in the Department of Cellular and Molecular Medicine at the University

Paul Insel is Distinguished Professor of Pharmacology and Medicine at UC San Diego, where he also co-directs Paul Insel on the web Insel Laboratory Institute of Engineering in Medicine UC San Diego UCSD Profiles

Jennifer Pluznick is Associate Professor of Physiology at Johns Hopkins University School of Medicine Jennifer is currently an assistant professor of physiology at the Johns Hopkins School of Medicine. from Truman State University and earned her Ph.D. in renal physiology from the University of Nebraska Medical

considerations shaped the fate of the EP4 partial agonist that ultimately found a niche in veterinary medicine angiotensin-related sequences, development of an EP4 partial agonist, and its path into veterinary medicine

She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology Cardarelli received her Ph.D. in Physiology from Albany Medical College. Dr.

From the early days of ion channel chemistry to pioneering peptide–fluorophore conjugates for the GLP Collaborated across chemistry and biology and felt the translation gap firsthand… …this episode will Broichhagen is a chemical biologist whose work sits at the intersection of organic synthesis, peptide chemistry Born in 1984, he studied chemistry at the University of Erlangen-Nuremberg (2004–2010) and completed His lab integrates synthetic chemistry, theoretical chemistry, cell biology, and imaging to understand

Stephen Ferguson’s laboratory in the Departments of Cellular & Molecular Medicine and Neuroscience at

(MFI): a reliable, self-sustaining computational chemistry service provider, developing its own software I am now combining my training as a chemist and as an entrepreneur to grow a sustainable service and

Bridging computation, chemistry, and pharmacology is key to speeding up drug discovery. when building a research career Who Should Listen GPCR scientists and pharmacologists Computational chemists With a reputation for collaborative science, Jens is a strong advocate for bringing together chemists

His research combines peptide chemistry, chemical biology, and nanobody engineering to build mechanistic Trained in the Gelman lab at the University of Wisconsin-Madison and later in the Ploegh lab at Harvard Medical Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Chemistry He earned his Ph.D. in Chemistry at the University of Wisconsin-Madison in the lab of Sam Gellman on Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and

Adriano Marchese Medical College of Wisconsin Bryan Roth UNC Chapel Hill Medical School Dmitry Veprintsev University of Nottingham Kenneth Jacobson NIH Matteo Pavan NIH Sudarshan Rajagopal Duke University School of Medicine Calebiro University of Birmingham Jakob Höppner Endocrine Unit, Massachusetts General Hospital and Harvard Medical

pharmacy in Iran before completing his master's and PhD in the Department of Cellular and Molecular Medicine

Strategic Partner(s) Silvio Gutkind: When GPCRs Drive Cancer GPCRs are the most drugged protein family in medicine

ABOUT RANDY Randy Hall is Professor of Pharmacology and Chemical Biology at Emory University School of Medicine

Western Australia sits at the intersection of assay technology, receptor pharmacology, and translational medicine - and watching protein levels fall in patients' urine is, for him, the reason most scientists enter medical That is really why I think most people get into medical research. It's very humbling." He is Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry Perkins Institute of Medical Research, Deputy Director of the Australian Research Council Centre for

GUESTS Alexander Ball is a senior scientist at GeneTex who joined the company in 2012 after training in medicine path from stem cell biology PhD to leading antibody characterization programs 12:20 Ball's path from medical

audio before use. 00:00 Welcome and introduction of David Gloriam 02:23 Career origins - from childhood medicine

With a career spanning two decades at the intersection of fluorescence chemistry, functional assays, How collaborations with David Parker and Jean-Philippe Pin accelerated both probe chemistry and biological Originally trained as a physicist with a strong interest in photophysics and fluorescence chemistry, His passion lies in turning cutting-edge probe chemistry into robust, scalable tools for drug discovery

limitations of baclofen 16:17 - The case for resolving disease isoform structures as a path toward precision medicine

Matthew Eddy Matthew Eddy earned his BA in Chemistry from Oberlin College, where he trained with solid-state He then earned his Ph.D. in physical chemistry from the Massachusetts Institute of Technology, training

While a chemistry undergraduate student at the University of Chicago, he attended a NATO Advanced Study After medical school and clinical training at Massachusetts General Hospital, Tom joined the laboratory Gobind Khorana at the Department of Chemistry at M.I.T. for postdoctoral training, where he learned gene After moving to Rockefeller University with a Howard Hughes Medical Institute appointment, Tom advanced including Richard Mathies and Fritz Siebert , and contributed substantially to elucidating the physical chemistry

The conversation traces the scientific and personal logic behind each transition: from chemistry to pharmacology Use as a navigational guide. 00:00 Introduction and ecosystem announcements 02:15 From inorganic chemistry Kathryn obtained her BS in Chemistry from Carnegie Mellon University and went on to receive a Ph.D. in

Kaavya Krishna Kumar on the web Journal of Biology Chemistry Stanford University Google Scholar LinkedIn